StockData

Rein Therapeutics vs Tvardi Therapeutics

RNTX and TVRD side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How RNTX and TVRD compare

Rein Therapeutics is the larger company, worth 2.4 times as much as Tvardi Therapeutics ($34.5M against $14.7M).

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricRNTXTVRD
Size and price
Market cap$34.5M$14.7M
Share price$0.400$1.10
Change, 1 year−70.4%−73.2%
Change, 5 years−97.0%−99.8%
Beta (5Y)2.182.71
Employees1012
StockData Score
Total score66
Valuation score11
Growth score00
Performance score00
Health score55
Dividend score00
Valuation
P/B0.6× (better)1.8×
Profitability
Return on equity−96.4% (better)−126%
Return on invested capital−145%–
Financial health
Debt / equity0.000.00
Current ratio4.27 (better)1.87
Altman Z-score−8.75 (better)−13.50
Piotroski F-score2 (better)1
Dividends and buybacks
Dividend yield0.00%0.00%
Years of dividend growth00
Buyback yield−159%–
Shareholder yield−159%0.00% (better)
Ownership
Held by institutions47.3%16.7%
Held by insiders9.6%15.6%
Insider net buying, 12 months$74.7K–
Short interest, % of float0.91%2.7%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.